Báo cáo thường niên năm 2023 của Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc. has developed the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient’s unique breathing patterns. Inspire therapy is designed … More to reduce OSA severity and improve quality of life for patients living with this challenging condition.